BR0316099A - Agentes antidiabéticos - Google Patents
Agentes antidiabéticosInfo
- Publication number
- BR0316099A BR0316099A BR0316099-8A BR0316099A BR0316099A BR 0316099 A BR0316099 A BR 0316099A BR 0316099 A BR0316099 A BR 0316099A BR 0316099 A BR0316099 A BR 0316099A
- Authority
- BR
- Brazil
- Prior art keywords
- antidiabetic agents
- prodrugs
- compounds
- diabetic
- hyperinsulinemia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Abstract
"AGENTES ANTIDIABéTICOS". A presente invenção refere-se a compostos de fórmula (I) as pró-drogas destes, e os sais farmaceuticamente aceitáveis dos compostos e pró-drogas, em que R<39>, R<39><39>, R<39><39><39>, e Z são como definido aqui; composições farmacêuticas destes; e usos destes no tratamento de diabetes, resistência à insulina, neuropatia diabética, nefropatia diabética, retinopatia diabética, cataratas, hiperglicemia, hipercolesterolemia, hipertensão, hiperinsulinemia, hiperlipidemia, arterosclerose, e isquemia de tecidos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42462702P | 2002-11-07 | 2002-11-07 | |
PCT/IB2003/004775 WO2004041780A2 (en) | 2002-11-07 | 2003-10-27 | N-(indole-2-carbonyl) amides as anti-diabetic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0316099A true BR0316099A (pt) | 2005-09-27 |
Family
ID=32312844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0316099-8A BR0316099A (pt) | 2002-11-07 | 2003-10-27 | Agentes antidiabéticos |
Country Status (8)
Country | Link |
---|---|
US (1) | US6992101B2 (pt) |
EP (1) | EP1562899A2 (pt) |
JP (1) | JP2006507294A (pt) |
AU (1) | AU2003274462A1 (pt) |
BR (1) | BR0316099A (pt) |
CA (1) | CA2503727A1 (pt) |
MX (1) | MXPA05004968A (pt) |
WO (1) | WO2004041780A2 (pt) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0205176D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205170D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205175D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205162D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205166D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205165D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0222909D0 (en) | 2002-10-03 | 2002-11-13 | Astrazeneca Ab | Novel process and intermediates |
GB0222912D0 (en) | 2002-10-03 | 2002-11-13 | Astrazeneca Ab | Novel process and intermediates |
NZ548212A (en) | 2003-12-29 | 2010-07-30 | Sepracor Inc | Pyrrole and pyrazole DAAO inhibitors |
WO2006055435A1 (en) | 2004-11-15 | 2006-05-26 | Bristol-Myers Squibb Company | 2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors |
US7214704B2 (en) | 2004-11-15 | 2007-05-08 | Bristol-Myers Squibb Company | 2-Amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
US7365061B2 (en) | 2004-11-15 | 2008-04-29 | Bristol-Myers Squibb Company | 2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
WO2006055462A1 (en) | 2004-11-15 | 2006-05-26 | Bristol-Myers Squibb Company | 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
WO2006060382A2 (en) * | 2004-11-30 | 2006-06-08 | Trustees Of The University Of Pennsylvania | Use of hdac and/or dnmt inhibitors for treatment of ischemic injury |
KR100886084B1 (ko) * | 2005-12-06 | 2009-02-26 | 주식회사 엘지화학 | 코어-쉘 형태의 나노입자 및 그 제조방법 |
KR101381768B1 (ko) | 2006-01-06 | 2014-04-07 | 선오비온 파마슈티컬스 인코포레이티드 | 테트랄론-기재 모노아민 재흡수 저해제 |
JP5432526B2 (ja) | 2006-01-06 | 2014-03-05 | サノビオン ファーマシューティカルズ インク | モノアミン再取り込み阻害剤としてのシクロアルキルアミン |
AU2007233041B2 (en) | 2006-03-31 | 2013-05-02 | Sepracor Inc. | Preparation of chiral amides and amines |
PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
US7884124B2 (en) | 2006-06-30 | 2011-02-08 | Sepracor Inc. | Fluoro-substituted inhibitors of D-amino acid oxidase |
US7902252B2 (en) | 2007-01-18 | 2011-03-08 | Sepracor, Inc. | Inhibitors of D-amino acid oxidase |
NZ580429A (en) | 2007-05-31 | 2012-04-27 | Sepracor Inc | Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6107329A (en) * | 1995-06-06 | 2000-08-22 | Pfizer, Inc. | Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors |
US6297269B1 (en) * | 1995-06-06 | 2001-10-02 | Pfizer Inc. | Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
DK1088824T3 (da) * | 1999-09-30 | 2004-04-13 | Pfizer Prod Inc | Bicykliske pyrrolylamider som glycogen phosphorylase inhibitorer |
GB0021831D0 (en) * | 2000-09-06 | 2000-10-18 | Astrazeneca Ab | Chemical compounds |
MXPA03000966A (es) * | 2002-02-28 | 2003-09-04 | Pfizer Prod Inc | Agentes antidiabeticos. |
GB0205176D0 (en) * | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
-
2003
- 2003-10-27 EP EP03758438A patent/EP1562899A2/en not_active Withdrawn
- 2003-10-27 MX MXPA05004968A patent/MXPA05004968A/es unknown
- 2003-10-27 AU AU2003274462A patent/AU2003274462A1/en not_active Abandoned
- 2003-10-27 WO PCT/IB2003/004775 patent/WO2004041780A2/en not_active Application Discontinuation
- 2003-10-27 JP JP2004549452A patent/JP2006507294A/ja active Pending
- 2003-10-27 CA CA002503727A patent/CA2503727A1/en not_active Abandoned
- 2003-10-27 BR BR0316099-8A patent/BR0316099A/pt not_active IP Right Cessation
- 2003-11-06 US US10/703,035 patent/US6992101B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6992101B2 (en) | 2006-01-31 |
CA2503727A1 (en) | 2004-05-21 |
US20040157907A1 (en) | 2004-08-12 |
WO2004041780A3 (en) | 2005-05-19 |
MXPA05004968A (es) | 2005-08-02 |
EP1562899A2 (en) | 2005-08-17 |
JP2006507294A (ja) | 2006-03-02 |
AU2003274462A1 (en) | 2004-06-07 |
AU2003274462A8 (en) | 2004-06-07 |
WO2004041780A2 (en) | 2004-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0316099A (pt) | Agentes antidiabéticos | |
BRPI0409952A (pt) | agentes anti-diabéticos | |
BR0300314A (pt) | Agentes antidiabéticos | |
PT1088824E (pt) | Pirrolil-amidas biciclicas como inibidores de glicogenio-fosforilase | |
BRPI0410760A (pt) | compostos, processo para fabricação dos mesmos, composições farmacêuticas e uso deste compostos | |
BR0214342A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
BR0214344A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
ES2318577T3 (es) | Derivados de cicloalquil lactama como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1'. | |
BR0212378A (pt) | Inibidores de 17beta-hidroxiesteróide desidrogenase tipo 3 para o tratamento de doenças dependentes de androgênio | |
BRPI0116607B8 (pt) | derivados de glicopiranosiloxipirazol , composições farmacêuticas que os contêm e usos dos mesmos | |
BR122020005056A8 (pt) | Método para preparar uma preparação oral que compreende cloridrato de n-[4-[4-(1,2-benziso-tiazol-3-il)-1-piperazinil]-(2r,3r)-2,3-tetrametileno-butil]-(1r,2s,3r,4s)-2,3-biciclo[2,2,1]heptanodicarboxiimida (lurasidona) | |
BRPI0409465A (pt) | derivados de carboxamida como agentes antidiabéticos | |
BR0212008A (pt) | Uso de um composto ou de um sal, solvato ou pró-medicamento deste, composição farmacêutica, composto ou um sal, solvato ou pró-medicamento deste, e, processo para a preparação deste | |
BR0009864A (pt) | Composto, composição farmacêutica, métodos para o tratamento de doenças, para o tratamento e/ou prevenção de condições mediadas pelos receptores nucleares e para o tratamento e/ou prevenção de diabete e/ou obesidade, e, uso de um composto | |
BR0312513A (pt) | Derivados de glicosìdeo de tiofeno, processos para a produção dos mesmos, medicamentos que contêm esses compostos e uso dos mesmos | |
UY27333A1 (es) | Nucleótidos 4` sustituidos | |
BR0316595A (pt) | Composto, método para a preparação de compostos, composição farmacêutica e usos do composto | |
BR9910583A (pt) | Aminotetralinas n-substituìdas como ligantes para o receptor de neuropeptìdeo y y5 úteis no tratamento de obesidade e outros distúrbios | |
BR0013368A (pt) | Uso de um composto, composto, e, composição farmacêutica | |
EA200870460A1 (ru) | Производные циклогексилпиразол-лактама в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы 1 | |
BR0315047A (pt) | Composto, composição fermacêutica que compreende o mesmo, processo para a preparação da composição farmacêutica, utilização dos compostos, método de tratamento e processo para a preparação do composto | |
BR0205829A (pt) | Novas aminas como ligantes dos receptores de histamina-3 e suas aplicações terapêuticas | |
DE502005010427D1 (de) | Physiologisch aktive zusammensetzung gegen diabetes | |
ATE428422T1 (de) | Piperidin-derivate als ccr3-antagonisten | |
BR0214675A (pt) | Novos compostos e seu uso em medicina, processo para seu preparo e composições farmacêuticas contendo os mesmos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE 4A., 5A., 6A, E 7A. ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2073 DE 28/09/2010. |